Key result
Exosomal non-coding RNAs play a critical role in pathological cardiac remodeling processes such as hypertrophy, apoptosis, and fibrosis, serving as potential therapeutic targets.
Why the study?
Exosomal non-coding RNAs play an important role in pathological cardiac remodeling, warranting a review of their origins, functions, and clinical applications.
This review highlights the potential of exosomal non-coding RNAs as therapeutic targets or biomarkers in pathological cardiac remodeling.
Answers are grounded in this paper and cite their sources.
Exosomal ncRNAs may drive cardiac remodeling; leaves open their biomarker or therapeutic utility pending prospective validation.
Exosomes are vesicles with a size range of 50 to 200 nm and released by different cells, which are essential for the exchange of information between cells. They have attracted a lot of interest from medical researchers. Exosomal non-coding RNAs play an important part in pathological cardiac remodelings, such as cardiomyocyte hypertrophy, cardiomyocyte apoptosis, and cardiac fibrosis. This review summarizes the origins and functions of exosomes, the role of exosomal non-coding RNAs in the process of pathological cardiac remodeling, as well as their theoretical basis for clinical application.
No takes yet. Share an insight, caveat, or question.
Lyu et al. (2023) conducted a review in Cardiac Remodeling. Exosomal non-coding RNAs was evaluated. Exosomal non-coding RNAs play a critical role in pathological cardiac remodeling processes such as hypertrophy, apoptosis, and fibrosis, serving as potential therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: